Is Pfizer Stock After Years Of Decline? Or Will Seagen Bolster Sales?
stock, which peaked in December 2021, has now fallen for two years as the drugmaker looks for its next big break after developing the first Covid vaccine with Germany's BioNTech (BNTX). Notably, Pfizer wrapped up its $43 billion acquisition of cancer-focused biotech Seagen last month. The deal…
#bntx #pfizer #seagen #padcev #merck #fda #tivdak #albertbourla #elrexfio #novonordisk